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Disease-specific survival and locoregional control in tonsillar carcinoma
In a nationwide survey on oropharyngeal carcinoma in the Netherlands (1986-1990), 380 patients with a 
tonsillar carcinoma were retrospectively studied. The records o f 268 (71 %) men and 112 (29%) women 
with a median age o f 59 yr (range 31-91), who had squamous cell carcinoma (272 patients, 98%) or 
undifferentiated carcinoma (8 patients, 2%) were reviewed with respect to treatment, disease-specific 
survival and locoregional control. Distribution by stage according to the U IC C ’92 system was: 27 patients 
(7%) stage I, 59 (15%) stage II, 99 (26%) stage III, 182 (48%) stage IV and 13 patients (3%) unknown 
stage. Using a previously reported revised staging system the following distribution was obtained: 118 
patients (31%) stage 1 ,120 (31%) stage II, 67 (18%) stage III, 54 (14%) stage IV and 21 patients (6%) 
with an unknown stage. Treatment consisted o f radiotherapy alone in 231 patients (61 %), surgery and 
radiotherapy in 101 (27%), surgery alone in 30 (8%), chemotherapy in 5 (2%) and 13 patients (3%) did 
not receive any treatment. At 5-yr the overall survival was 32%, the disease-specific survival 42% and the 
locoregional control 61%. In patients treated with radiotherapy alone the disease-specific survival was 
39%, for surgery and radiotherapy 53% and for surgery alone 83%. The disease-specific survival according 
to UICC’92 stage was 71 % in stage I, 59% in II, 50% in III and 32% in stage IV (P  <  0.0001). In the 
revised staging the survival figures were 63% in stage I, 43% in II, 31 % in III and 9% in IV (P  <  0.0001). 
The two staging systems appeared to be comparable in prognostic discrimination; the clinical relevance 
of the revised stage might, however, be slightly superior to the UICC’92 version. The difference in results 
after radiotherapy alone and surgery +  radiotherapy remained significant, also after adjusting for stage 
(P <  0.0001).
Keywords tonsillar carcinoma survival locoregional control
The tonsillar region is the most frequent site of cancer in the with two other subsites in the oropharynx, i.e. the base of the
OnlyU 15oropharynx. “* Despite the advanced stage of the disease at tongue,8 11 and the posterior oropharyngeal wall, 
first presentation in the majority o f patients,4"7 better treat- soft palate lesions have a similar or slightly better prognosis 
ment results are reported in these tumours,4 7 when compared than tonsillar cancers.15
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The hypothesis that the subsite constitutes not only a sep­
arate clinical entity but also forms an independent prognostic 
factor in oropharyngeal carcinoma1(1 was recently tested in the 
frame o f  a nationwide study in the Netherlands on a group of
550 (O 1996 Blackwell Science Ltd
Table 1. The revised staging system for oropharyngeal carcinoma.18 
The T, N and M categories are identical as in the U IC C 92/A JC C 88  
system
Stage I T 1-2 N 0 -1 M 0
Stage II T 1-2 N 2 M 0
T 3 N 0-1 M 0
T 4 NO M 0
Stage III T 1-2 N 3 M 0
T 3 N 2 M 0
T 4 N 1 M 0
Stage IV T 3 N  3 M 0
T 4 N 2-3 M 0
Any T Any N M 1
were identified by cross-checking o f  epidemiological data, and 
the totals were adjusted accordingly.
The records of patients analysed previously were updated 
with respect to the data on locoregional control, resulting in 
a total of 653 patients with oropharyngeal carcinoma. The 
results of the 380 patients with tonsillar carcinoma are pre­
sented in this paper.
DEFINITIONS AND STATISTICAL ANALYS I S
Patients were followed for a minimum o f  3 yr or until death. 
Treatment of patients with either residual locoregional 
tumour or a locoregional recurrence was considered a failure. 
Patients with distant métastasés only were censored at the
640 patients, treated between 1986 and 1990.17 In univariate time of diagnosis of métastasés. Other patients were censored
analysis, tumours in the tonsillar region were associated with 
better survival. However, on multivariate analysis other 
factors, i.e. midline origin o f the tumour, a revised staging 
system and sex, emerged statistically as more significant than 
the subsite.18
The revised staging system, mentioned here, comprises a 
modified combination o f the existing TNM  categories for this 
patient population (Table 1), which was compared with the 
current UICC’92/AJCC’88 staging system.19 This revised stag­
ing seems to provide a better prognostic discrimination for 
disease-specific survival. The relevance of the revised staging 
on different subsites in this series and/or on other large series 
remains to be verified, but it seems obvious that the present 
staging systems are not yet optimal.
at the time of death or at the end o f  the follow-up. Three 
analyses were performed.
1 Identification of possible predictors for locoregional 
control, using a backward elimination procedure of vari­
ables related to treatment, tum our and epidemiology. A
18detailed list o f the variables has been published previously.
2 Comparison of the three main treatment groups (radio­
therapy alone, surgery and radiotherapy, and surgery alone) 
with respect to locoregional control, adjusted for the prog­
nostic variables identified from the first analysis.
3 A test of the differences between patients treated by radio­
therapy alone versus surgery and radiotherapy with respect 
to stage (UICC’92), by studying two-way interactions 
between treatment and stage.
In all multivariate analyses the proportional hazard model 
and locoregional control are investigated and the effects of was used. P-values were calculated from the likelihood ratio 
the revised staging system are further analysed. statistics. Univariate curves were computed using the life table
method with 1-month intervals or the product-limit method.
18.20.21
In this paper carcinoma of the tonsillar region is studied as 
a single clinical entity. Treatment results in terms o f survival
Patients and methods Adjusted curves were calculated from the cumulative hazardfunction, estimated according to the method of Link.22 The 
variable for which the curves had to be calculated was used 
as stratum variable, whereas the variables that had to be 
adjusted for were included in the model as covariates. The 
curves were calculated at approximate mean values of the 
covariates in the whole group.
PATIIÎNTS
As reported earlier, 17.IK the study was conducted in seven
major referral centres, participating in the Dutch Head and 
Neck Cooperative Oncology Group: the University Hospitals 
o f Groningen, Leiden and Maastricht in combination with 
the Radiotherapeutic Institute Limburg, Nijmegen and Rot­
terdam in cooperation with the Dr Daniel Den Hoed Cancer 
Center, Utrecht, and The Netherlands Cancer Institute, in 
combination with the University o f Amsterdam. In each par­
ticipating centre the charts o f  patients admitted for oro­
pharyngeal carcinoma between 1986 and 1990 were reviewed. 
Data related to epidemiology, staging, treatment and follow- 
up were collected using standardized checklists and returned 
as a hard copy to the Comprehensive Cancer Centre Amster-
Results
The group of 380 patients with tonsillar carcinoma consisted 
of 268 (71%) men and 112 (29%) wom en with a median age 
of 59 (31-93) yr.
dam (IKA). There, a centralized data entry, using a scientific 
information retrieval (SIR) database, version 3.2, was per­
formed. Patients who were admitted to more than one centre
Distribution by stage of the disease according to the UICC’92 
system was: 27 patients (7%) stage I, 59 (15%) stage II, 99 
(26%) stage III, 182 (48%) stage IV and 13 patients (3%) had
(r.) 1996 Blackwell Science Ltd, Clinical Otolaryngology, 21, 550- 556
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an unknown stage o f the disease. Distribution by the revised
staging system18 was: 118 patients (31 %) in stage I, 120 (31 %) 
in II, 67 (18%) in III, 54 (14%) in IV and 21 (6%) unknown.
TREATMENT AND SURVI VAL
Two hundred and ninety-eight patients (78%) were treated 
with intention to cure, 77 (20%) received palliative treatment
(2%) in stages HI—IV still receiving surgery as the only treat­
ment modality.
At 5 yr the overall survival was 32% and the disease-specific 
survival 42%, As can be seen from Figure 2, the disease- 
specific survival in patients treated with radiotherapy alone 
was 39%, with surgery and radiotherapy 53%, and with sur­
gery alone 83%.
The disease-specific survival in both staging systems, shown
and for five patients (2%) the intention to treat was not known in Figure 3, ranged from 71% in stage I to 32% in stage IV 
in retrospect. The treatment corresponded to the standard (P  <  0.0001) of the UICC’92 system and from 63% to 9%
protocol in operation in the participating centres in 325 pa- (P  <  0.0001) in the corresponding stages of the revised system, 
tients (85%), was different from the standard in 52 patients
(14%) and was unknown in the remaining three patients (1 %). ,,,
L O ( O R h Ct IC) N A L C O N I R O L
The main reasons for deviating from the standard treatment
were poor general condition in 15 patients (4%) and refusal The status at the end of the follow-up is shown in Table 2.
in 10 patients (3%); in all other patients but one (refusing The locoregional control at 5 yr was 61%. By treatment
standard treatment because o f  age), multiple reasons for devi- modality the 5-yr figures were 54% for radiotherapy alone,
ating from the standard protocols were given. 74% for surgery and radiotherapy, and 96% for surgery alone
Two hundred and thirty-one patients (61%) were treated (Figure 4).
with radiotherapy alone, 101 (27%) with surgery and radio­
therapy, 30 (8%) with surgery alone, five patients (2%) with 
chemotherapy alone, and the remaining 13 patients (3%) did 
not receive any treatment. The group o f 231 patients treated 
with radiotherapy alone also includes 27 patients who received 
primary radiotherapy but also underwent a neck dissection. 
These patients, the majority o f whom had (UICC’92) stage 
III—IV disease will be discussed separately. The treatment
When analysed separately, the 27 patients who underwent 
neck dissection followed by radiotherapy to the primary site, 
appeared to have a 5-yr disease-specific survival of 48% and 
a locoregional control o f 75%. Locoregional control by 
UICC’92 stage was: 92% in stage I, 75% in II, 66% in III and 
47% in IV (P  <  0.0001; Figure 5). In the revised staging sys­
tem the corresponding figures were 78%, 65%, 43% and 25% 
(P  <  0.0001; Figure 5).
modalities for stage UICC’92 and for the revised system are 
shown in Figure 1. In the revised staging system, surgery alone 
was used only in stages I-II and a steady relative increase o f  
patients treated with radiotherapy alone was seen from 7% in 
stage I to 70% in stage IV. In the UICC’92 system, this 
distribution was less apparent, with a total of seven patients
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Figure 1. Treatment modality per stage UICC’92 and revised staging
surgery +  RT.
ANALYSIS OF PROGNOSTI C VARIABLES FOR LOC’O- 
R E G IO N A L C 0  N T R O L
From the analysis o f prognostic variables for locoregional 
control only the stage, UICC’92 or revised, emerged as being 
clearly important {P  <  0.0001 throughout all steps). Due to a 
large overlap (high collinearity) o f the two staging systems, 
including both systems in the multivariate analysis would 
reduce their prognostic value to clear non-significance. There­
fore, most analyses were adjusted for UICC’92 stagi 
Adjusted for stage, there is a
only, 
patients
treated with radiotherapy alone had a worse
than patients treated with surgery and radiotherapy 
{P  <  0.0001, Figure 6). The 5-yr figures for the UICC’92 
stages were 80%) in stage I, 71 % in stage II, 63% in stage III, 
40% in stage IV. In the revised staging these figures were
100%, 100%, 71% and 68%, respectively.
The 27 patients from the radiotherapy group who also 
underwent a neck dissection had a favourable locoregional 
control compared to other patients treated with radiotherapy 
alone throughout all steps of the analysis {P  = 0.036).
Discussion
In this analysis a subset o f  380 patients with tonsillar carci­
noma, extracted from a larger group of 653 patients with
<D 1996 Blackwell Science Ltd, Clinical Otolaryngology* 21, 550-556
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oropharyngeal cancer were studied. Special attention has been stages I and II. Thus, according to the revised staging, tonsillar 
given to factors influencing the disease-specific survival, loco- tumours, with the majority of patients in earlier stages, seem
regional control and the relevance of a staging to form a favourable subgroup in the oropharynx. Moreover,
IKWith respect to the latter, it could be observed that the absence o f tumours in the midline, previously identified
the distribution o f patients in this revised staging system leads as a favourable prognostic factor for survival,18 might further
to a shift of approximately two-thirds o f patients towards explain the better treatment results in tonsillar carcinoma,
(p 1996 Blackwell Science Ltd, Clinical Otolaryngology, 21, 550 556
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Table 2. Vital status at the end o f the follow-up of 380 patients with therapy a lon e and co m b in a tio n  treatm ent was not p roven  to  
tonsillar carcinoma ke dependent on stage (interaction: P  =  0.073), a lth ou gh  it
seems to be more clearly present in stage IV.
The importance o f  complete tumour regression at the end 
of treatment could be demonstrated clearly through the dis­
appearance o f significant differences between both groups 
when patients with residual disease were excluded. Once a 
complete remission is reached, as almost by definition readily 
obtained with initial surgery, the prognosis is quite favourable 
through all stages. For radiotherapy it is known 
regression o f tumour during the treatment and total clearance 
at the end of radiotherapy and 6 weeks later predict the
Alive, NED* 140
Alive with tumour 7
Dead, NED 55
Dead with tumour 176
Unknown 2
*No evidence of disease
8-15when compared to most other subsites in the oropharynx.
The clinical relevance of the revised system is also indicated 
by the distribution of treatment modalities over the stages: in
tumour control very reliably. 1,8,10,23,24 Upon
residual disease and excluding those patients from further 
the revised version surgery alone was used only in stages I—II comparison, similar control rates were obtained with both 
and a steady increase of patients treated with radiotherapy modalities,
alone was observed from stage I to IV. In contrast, in the The issue o f selecting patients for surgery based on good
UICC’92 system, seven patients in stage III and IV still performance status cannot be addressed in this study, since
received surgery as their only treatment modality. these data, as in many other series, were not available. As
Also the range of the disease-specific survival and loco- stated previously,17 the standardized checklists designed for 
regional control in the four stages was wider in the revised this project only included well-defined, categorized basic data, 
staging compared to the UICC’92 system. However, multi- that were likely to be present in all or almost all patients’
variate analysis has shown a similar prognostic effect of both records. Despite the obvious importance of host charac-
staging systems when locoregional control was taken as the teristics in choosing treatment and predicting survival,16,25,26 a
end-point. These results are somewhat different from the out­
come of the analysis of all patients with oropharyngeal car­
cinoma having survival as the end-point. In that case the 
revised staging seemed to be superior to the UICC’92 system.18
systematic and structured inclusion of these items in patients’ 
records and study questionnaires has not been widely adopted. 
In this particular study we do know that in many clinics 
primary radiotherapy was often the therapy of choice, par-
However, the revised system was optimized for disease-specific ticularly in the lower UICC’92 stages.
survival in that patient group, so an unbiased comparison 
with other staging systems can only be performed in an inde­
pendent sample of patients. In testing the interaction of treat­
ment and stage, the relatively small group of 30 patients 
treated with surgery alone, was omitted from the analysis. It is 
obvious that this subgroup selection on favourable prognostic 
parameters (low age, good performance status, wide margins) 
plays too great a role for meaningful comparison. Inter­
estingly, the difference in locoregional control between radio-
In conclusion, the revised staging provided a shift o f  pa­
tients with tonsillar carcinoma towards lower stages and a 
wider spread of survival and locoregional control curves, when 
compared to the UICC’92 system. In the multivariate analysis 
of the prognostic factors, the revised staging appeared to be 
comparable to the UICC’92 staging system, but not superior 
to it. Treatment results o f the combination of surgery and 
radiotherapy were significantly better than those of radio­
therapy alone, also when adjusted for stage. Whether this is
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due to the treatment m od ality  itself, or to  confou nders thus ^  M ak-K regar S., Baris G., Liibesque J.V. et al. (1993) Radio-
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far unidentified, is still open for discussion.
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